Adolescent neurobehavioral outcomes after early nutrition: follow-up of a Bangladeshi trial
Official title: Neurobehavioral impacts in adolescence from early life nutrition supplementation: 10-year follow-up to a cluster randomized trial in Bangladesh
Funded at University of South Carolina at Columbia · NIH-11593343 · Data updated 2026-11-12
This project follows up on children who received nutrient-rich supplements in early life to see how it affects their brain development and behavior during adolescence.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Carolina at Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | July 1, 2026 |
| Project end | June 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $85,863 |
| NIH project number | 3R01HD118019-01A1S2 |
| Project ID | NIH-11593343 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adolescents who were part of the Rang-Din Nutrition Study cohort and their families.
✕Less likely to help
Adolescents not exposed to the early-life SQ-LNS intervention or without cohort data may not experience direct benefits.
What this research studies
Researchers will re-contact adolescents from a prior nutrition study to measure neurobehavioral outcomes, comparing those who received SQ-LNS in pregnancy and early childhood with those who did not. The study uses standardized behavioral and cognitive assessments, along with health and growth data, to understand long-term effects. The goal is to uncover whether early nutrition has lasting benefits on thinking, behavior, and everyday functioning as teens grow older.
Why it matters
Potential benefit: If successful, findings could inform maternal and child nutrition programs to support healthier brain development and better outcomes in adolescence.
How similar studies have gone: Some long-term nutrition studies show persistent benefits, but this follow-up adds new evidence for adolescent neurobehavioral outcomes.
Where this research is happening
-
University of South Carolina at Columbia
Columbia, United States Active
Researchers
- Principal investigator: Ghattas, Hala — University of South Carolina at Columbia
- Study coordinator: Ghattas, Hala
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.